Matches in Wikidata for { <http://www.wikidata.org/entity/Q92214277> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q92214277 description "article scientifique publié en 2019" @default.
- Q92214277 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92214277 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92214277 description "scientific article published on 18 December 2019" @default.
- Q92214277 description "wetenschappelijk artikel" @default.
- Q92214277 description "наукова стаття, опублікована 18 грудня 2019" @default.
- Q92214277 name "Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility" @default.
- Q92214277 name "Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility" @default.
- Q92214277 type Item @default.
- Q92214277 label "Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility" @default.
- Q92214277 label "Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility" @default.
- Q92214277 prefLabel "Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility" @default.
- Q92214277 prefLabel "Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility" @default.
- Q92214277 P1433 Q92214277-2D179863-FAFF-4230-975A-F8C52AD21F15 @default.
- Q92214277 P1476 Q92214277-384E297B-8EA7-42CB-9133-3EA5461F803B @default.
- Q92214277 P2093 Q92214277-2A216853-26AB-498B-BEAC-C1F5A925BA31 @default.
- Q92214277 P2093 Q92214277-4E176BBA-000D-4323-ACA8-6426001E14CF @default.
- Q92214277 P2093 Q92214277-4FF4FE5F-DC4F-4D4A-B939-015CADB65D42 @default.
- Q92214277 P2093 Q92214277-5970F623-DDDB-45E2-8AA2-16947834F828 @default.
- Q92214277 P2093 Q92214277-F7579E88-F70B-4F7A-A960-9E44E0CCC5C9 @default.
- Q92214277 P2093 Q92214277-FF1FF25E-A8FF-4009-B22B-9810A12D8090 @default.
- Q92214277 P304 Q92214277-723153F1-FDCC-4365-8647-24C3DB485B91 @default.
- Q92214277 P31 Q92214277-9A0D1707-BC1B-4844-AE72-700368D6A43B @default.
- Q92214277 P356 Q92214277-0AECB2DC-6ABA-4136-8569-0E8889CB3640 @default.
- Q92214277 P433 Q92214277-A690CBAE-87CF-46CB-9580-E888E2C8E889 @default.
- Q92214277 P478 Q92214277-6C16E5F3-BCFE-476B-9FAF-822DB9801FAE @default.
- Q92214277 P577 Q92214277-989C27CC-F394-4B1D-8C38-F951F573B085 @default.
- Q92214277 P698 Q92214277-D08A4502-DA92-4051-897D-D76C0527A159 @default.
- Q92214277 P921 Q92214277-3DFB8B68-8796-43C3-AC83-20D66FB9B370 @default.
- Q92214277 P356 J.BMCL.2019.126908 @default.
- Q92214277 P698 31870649 @default.
- Q92214277 P1433 Q2709483 @default.
- Q92214277 P1476 "Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility" @default.
- Q92214277 P2093 "Bruce D Hammock" @default.
- Q92214277 P2093 "Christophe Morisseau" @default.
- Q92214277 P2093 "Dmitry Karlov" @default.
- Q92214277 P2093 "Gennady M Butov" @default.
- Q92214277 P2093 "Vladimir Burmistrov" @default.
- Q92214277 P2093 "Vladimir D'yachenko" @default.
- Q92214277 P304 "126908" @default.
- Q92214277 P31 Q13442814 @default.
- Q92214277 P356 "10.1016/J.BMCL.2019.126908" @default.
- Q92214277 P433 "3" @default.
- Q92214277 P478 "30" @default.
- Q92214277 P577 "2019-12-18T00:00:00Z" @default.
- Q92214277 P698 "31870649" @default.
- Q92214277 P921 Q7558943 @default.